Advances in ALS NIH News in Health
4.9
(279) ·
$ 7.50 ·
In stock
Description
Research Advances Are Giving Hope to Patients with ALS
NIH launches three trials to fund experimental ALS drugs - Clinical Trials Arena
Medical science breakthroughs of 2022: ALS, diabetes, COVID
NINDS sets new priorities for ALS research to improve life quality, NIH branches will use new strategic plan to award funding
Neurodegenerative disease can progress in newly identified patterns, MIT News
Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis
NIH to fund unproven ALS drugs under patient-backed law, Health News, ET HealthWorld
Environmental Factor - July 2020: Innovative ALS research fueled by $25 million from NIH
Who is Lou Gehrig? The History of ALS
Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis - Brewer - Journal of Neurochemistry - Wiley Online Library
PDF] Advances in Patient-Reported Outcomes: The NIH PROMIS® Measures
NIH to fund unproven ALS drugs under patient-backed law - Alabama Daily News
Cells, Free Full-Text
Frontiers A Descriptive Review of Global Real World Evidence Efforts to Advance Drug Discovery and Clinical Development in Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis (ALS) National Institute of Neurological Disorders and Stroke
Related products
You may also like
copyright © 2019-2024 tlpa.aero all rights reserved.